Regeneron Pharmaceuticals Inc

REGN 
(NASDAQ) 
 
$ 314.25 <%= Resources.Global.txtDown %>
Updated 20/04/2018
Change % -0.50% Stock price decreasing
Change -1.58 Stock price decreasing
Volume 271,092
High $ 318.19
Low $ 311.34
Open $ 316.31
ISIN
Prev close $ 315.83
# of shares 105.79M
Market cap 33,243M USD
Intraday

Market closed
Regeneron Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  314.25 -1.2% Stock price decreasing -2.2% Stock price decreasing -17.7% Stock price decreasing -27.4% Stock price decreasing -15.1% Stock price decreasing
Powered by TradingView

News about Regeneron Pharmaceuticals Inc

  • English
  • Regulatory news

Company profile

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 April 2018 08:30:10
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180417.1 - EUROWEB5 - 2018-04-23 09:30:10 - 2018-04-23 08:30:10 - 1000 - Website: OKAY